What the Health? From KFF Health News - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

What the Health? From KFF Health News — Health
What the Health? From KFF Health News

Join Julie Rovner, chief Washington correspondent for KFF Health News, along with top health policy reporters from The New York Times, The Washington Post, Politico and other media outlets to discuss the latest news and explain what the health is going on here in Washington, D.C.

Copyright: © All rights reserved

Latest Episodes:

Delta Blues Aug 05, 2021

Show notes

Covid is back with a vengeance, with some people clamoring for booster shots while others harden their resistance to getting vaccinated at all. Meanwhile, the Food and Drug Administration is pushing hard on drugmaker Pfizer’s request to upgrade the emergency authorization for its vaccine and give it final approval. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite health policy stories of the week they think you should read, too.

Hosted on Acast. See acast.com/privacy for more information.

Hot Covid Summer Jul 29, 2021

Show notes

The summer that promised to let Americans resume a relatively normal life is turning into another summer of anxiety and face masks, as the delta variant drives covid caseloads up in all 50 states. Meanwhile, the Americans with Disabilities Act turns 35, and the Missouri Supreme Court orders the state to expand Medicaid after all. Mary Ellen McIntire of CQ Roll Call, Anna Edney of Bloomberg News and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Samantha Young, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about an Olympic-level athlete with an Olympic-size medical bill.

Hosted on Acast. See acast.com/privacy for more information.

Delta Changes the Covid Conversation Jul 22, 2021

Show notes

With covid cases on the upswing again around the country, partisan division remains over how to address the pandemic. Meanwhile, the Biden administration proposes bigger penalties for hospitals that fail to make their prices public as required. Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Tami Luhby of CNN join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite stories of the week they think you should read, too.

Hosted on Acast. See acast.com/privacy for more information.

Here Comes Reconciliation Jul 15, 2021

Show notes

Democrats in Congress reached a tentative agreement to press ahead on a partisan bill that would dramatically expand health benefits for people on Medicare, those who buy their own insurance and individuals who have been shut out of coverage in states that didn’t expand Medicaid. Meanwhile, controversy continues to rage over whether vaccinated Americans will need a booster to protect against covid-19 variants, and who will pay for a new drug to treat Alzheimer’s disease. Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Rae Ellen Bichell, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a mother and daughter who fought an enormous emergency room bill.

Hosted on Acast. See acast.com/privacy for more information.

Becerra Urges Congress to Expand Medicare, Address Rx Prices Jul 13, 2021

Show notes

Health and Human Services Secretary Xavier Becerra is the special guest for this bonus episode of KHN’s “What the Health?” podcast. He and host Julie Rovner discuss a breadth of topics the secretary oversees, including covid-19, prescription drug prices, Medicare, Medicaid and the Affordable Care Act.

Hosted on Acast. See acast.com/privacy for more information.

Un-Trumping the ACA Jul 01, 2021

Show notes

The Biden administration is moving to undo many of the changes the Trump administration made to the enrollment process for the Affordable Care Act to encourage more people to sign up for health insurance. Meanwhile, Congress is opening investigations into the controversial approval by the Food and Drug Administration of an expensive drug that might (or might not) slow the progression of Alzheimer’s disease. Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Marshall Allen of ProPublica about his new book, “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”

Hosted on Acast. See acast.com/privacy for more information.

How to Expand Health Coverage Jun 24, 2021

Show notes

Democrats in Congress and the states are devising strategies to expand health coverage — through the Affordable Care Act, Medicare, Medicaid and a “public option.” But progress remains halting, at best. Meanwhile, lawmakers in Washington may have to agree on how to control prescription drug prices if they wish to finance their coverage initiatives. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Michelle Andrews, who reported and wrote last month’s KHN-NPR “Bill of the Month” episode about a very expensive sleep study.

Hosted on Acast. See acast.com/privacy for more information.

The ACA Lives Jun 18, 2021

Show notes

In a surprisingly strong 7-2 decision, the Supreme Court turned back the latest constitutional challenge to the Affordable Care Act, likely heralding the end of GOP efforts to strike the law in its entirety through court action. Meanwhile, Democratic lawmakers are looking for ways to expand health benefits. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Andy Slavitt, who recently stepped down from the Biden administration’s covid response team, about his new book on the pandemic.

Hosted on Acast. See acast.com/privacy for more information.

Our 200th Episode! Jun 10, 2021

Show notes

The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.

Hosted on Acast. See acast.com/privacy for more information.

The Drug Price Dilemma Jun 03, 2021

Show notes

Republicans, Democrats and the public at large agree that prices for prescription drugs are too high. But no one seems to know how to fix it. Vanderbilt University drug price researcher Stacie Dusetzina explains the basics of why drugs cost so much and why it’s hard to do something about it. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the prospects for policy changes.

Hosted on Acast. See acast.com/privacy for more information.

Related Podcasts